| Literature DB >> 30686255 |
Junfu Zhang1,2, Liying Wang3, Xinru You3, Tuzeng Xian2, Jun Wu3,4, Jun Pang1.
Abstract
Traditional prostate cancer therapy and especially chemotherapy has faced many challenges. Low accumulation levels, rapid clearance or drug resistance at the tumor site have been central to why the effect of chemotherapy drugs has declined. Applications of nanotechnology to biomedicine have enabled the development of nanoparticle therapeutic carriers suited for the delivery of chemotherapeutics in cancer therapy. This review describes the current nature of nanoparticle therapeutic carriers for prostate cancer. It describes typical nanocarriers commonly used for the delivery of chemotherapy or for imaging examination. Targeting strategies and related influencing factors are investigated to find ways of enhancing treatment effects of nanoparticles. The overall purpose of this review is to further understanding and to offer recommendations on the design and development of therapeutic nanoparticles for prostate cancer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Chemotherapy; Drug delivery; ERP effect; Nanoparticles; Prostate cancer; Targeting strategies.
Mesh:
Substances:
Year: 2019 PMID: 30686255 DOI: 10.2174/1568026619666190125145836
Source DB: PubMed Journal: Curr Top Med Chem ISSN: 1568-0266 Impact factor: 3.295